Nanotechnology approaches in the current therapy of skin cancer

dc.contributor.authorBorgheti Cardoso, Livia Neves
dc.contributor.authorViegas, Juliana Santos Rosa
dc.contributor.authorSilvestrini, Ana Vitoria Pupo
dc.contributor.authorCaron, Angelo Luis
dc.contributor.authorPraça, Fabiola Garcia
dc.contributor.authorKravicz, Marcelo
dc.contributor.authorLopes Badra Bentley, Maria Vitória
dc.date.accessioned2020-05-11T11:34:08Z
dc.date.available2021-02-27T06:10:20Z
dc.date.issued2020-02-27
dc.date.updated2020-05-08T18:01:28Z
dc.description.abstractSkin cancer is a high burden disease with a high impact on global health. Conventional therapies have several drawbacks; thus, the development of effective therapies is required. In this context, nanotechnology approaches are an attractive strategy for cancer therapy because they enable the efficient delivery of drugs and other bioactive molecules to target tissues with low toxic effects. In this review, nanotechnological tools for skin cancer will be summarized and discussed. First, pathology and conventional therapies will be presented, followed by the challenges of skin cancer therapy. Then, the main features of developing efficient nanosystems will be discussed, and next, the most commonly used nanoparticles (NPs) described in the literature for skin cancer therapy will be presented. Subsequently, the use of NPs to deliver chemotherapeutics, immune and vaccine molecules and nucleic acids will be reviewed and discussed as will the combination of physical methods and NPs. Finally, multifunctional delivery systems to codeliver anticancer therapeutic agents containing or not surface functionalization will be summarized.ca
dc.format.extent27 p.
dc.format.mimetypeapplication/pdf
dc.identifier.issn0169-409X
dc.identifier.urihttps://hdl.handle.net/2445/159637
dc.language.isoengca
dc.publisherElsevierca
dc.relation.isformatofVersió postprint del document publicat a: http://dx.doi.org/10.1016/j.addr.2020.02.005
dc.relation.ispartofAdvanced Drug Delivery Reviews, 2020
dc.relation.urihttp://dx.doi.org/10.1016/j.addr.2020.02.005
dc.rightscc by-nc-nd (c) Elsevier, 2020
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/es/
dc.sourceArticles publicats en revistes (ISGlobal)
dc.subject.classificationCàncer de pell
dc.subject.classificationNanotecnologia
dc.subject.otherSkin cancer
dc.subject.otherNanotechnology
dc.titleNanotechnology approaches in the current therapy of skin cancerca
dc.typeinfo:eu-repo/semantics/articleca
dc.typeinfo:eu-repo/semantics/acceptedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
Borgheti-Cardoso_L_N_Avd_Drug_Deliv_Rev_2020.pdf
Mida:
2.81 MB
Format:
Adobe Portable Document Format